Advertisement
Research Article

A Longitudinal Study of Medicaid Coverage for Tobacco Dependence Treatments in Massachusetts and Associated Decreases in Hospitalizations for Cardiovascular Disease

  • Thomas Land mail,

    Thomas.Land@state.ma.us

    Affiliation: Massachusetts Tobacco Cessation and Prevention Program, Boston, Massachusetts, United States of America

    X
  • Nancy A. Rigotti,

    Affiliations: Tobacco Research and Treatment Center, General Medicine Division, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America, Mongan Institute for Health Policy, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America

    X
  • Douglas E. Levy,

    Affiliations: Tobacco Research and Treatment Center, General Medicine Division, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America, Mongan Institute for Health Policy, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America

    X
  • Mark Paskowsky,

    Affiliation: Massachusetts Tobacco Cessation and Prevention Program, Boston, Massachusetts, United States of America

    X
  • Donna Warner,

    Affiliation: Massachusetts Tobacco Cessation and Prevention Program, Boston, Massachusetts, United States of America

    X
  • Jo-Ann Kwass,

    Affiliation: Massachusetts Tobacco Cessation and Prevention Program, Boston, Massachusetts, United States of America

    X
  • LeAnn Wetherell,

    Affiliation: Office of Medicaid Commonwealth of Massachusetts, Boston, Massachusetts, United States of America

    X
  • Lois Keithly

    Affiliation: Massachusetts Tobacco Cessation and Prevention Program, Boston, Massachusetts, United States of America

    X
  • Published: December 07, 2010
  • DOI: 10.1371/journal.pmed.1000375

About the Authors

Thomas Land, Mark Paskowsky, Donna Warner, Jo-Ann Kwass, Lois Keithly
Massachusetts Tobacco Cessation and Prevention Program, Boston, Massachusetts, United States of America
Nancy A. Rigotti, Douglas E. Levy
Tobacco Research and Treatment Center, General Medicine Division, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America
Nancy A. Rigotti, Douglas E. Levy
Mongan Institute for Health Policy, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America
LeAnn Wetherell
Office of Medicaid Commonwealth of Massachusetts, Boston, Massachusetts, United States of America

Corresponding Author

Email: Thomas.Land@state.ma.us

Competing Interests

In the past 5 years, NAR's institution has received research grant funding from Pfizer and Nabi Biopharmaceuticals for the study of investigational and/or marketed smoking cessation products. She has consulted for Pfizer and Free & Clear. She does not accept payment for consultation and has not for the past two years.

Author Contributions

ICMJE criteria for authorship read and met: TL NAR DEL MP DW JAK LW LK. Agree with the manuscript's results and conclusions: TL NAR DEL MP DW JAK LW LK. Designed the experiments/the study: TL DEL DW JAK LK. Analyzed the data: TL DEL MP LW. Collected data/did experiments for the study: TL MP LW. Wrote the first draft of the paper: TL. Contributed to the writing of the paper: NAR DEL DW JAK LW LK. Advised on design and analysis plan: NAR. Oversaw study design, contributed to implementation, and oversaw evaluation of MassHealth benefit: LK.